glp 1 risks Risk of pancreatic cancer associated with GLP-1 receptor agonist therapy Do The Benefits of GLP-1

2007;2(12):e1272

SIRT3 regulation of mitochondrial oxidative stress

FDA convened this weeks meeting to discuss seven unapproved peptides that are under review for various medical conditions, including ulcerative colitis, migraines and opioid addiction

Consistency matters more than exact timing

Univariable logistic regression was performed for the primary outcome moderate-to-severe BPD among survivors at 36 weeks postmenstrual age, as well as the secondary outcomes

Nec-1 functions through the specifically targeting of Receptor-Interacting Protein Kinase 1 (RIPK1), inducing disruption in the assembly of the necrosome, consequently impeding the execution of necroptotic cell death